Fierce Pharma Biopharma News & Insights
WEBFierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Health & Pharma News | Latest Healthcare Stories | Reuters
WEB4 days ago · Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news coverage.
Pharmaceuticals sector - Financial Times
WEBSep 26, 2024 · Comprehensive coverage of the pharmaceuticals industry. The latest news and developments from the world's leading drug companies, including Pfizer, Johnson & Johnson, AstraZeneca and more.
Pharma Industry - Latest News, Investigations and Analysis
WEBSep 27, 2024 · The latest news on health and wellness, including the healthcare industry, pharmaceuticals and more.
Biotech and Pharma Industry News | BioPharma Dive
WEBBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
Pharmaceuticals News - ScienceDaily
WEB6 days ago · Research news on the pharmaceutical industry including new drugs and interventions.
Pharma News | BioPharma Dive
WEB6 days ago · Biosimilar competition to aging blockbusters will erode a large chunk of the pharma giant’s top line over the next few years. Looming patent expiries later this decade are pushing large pharmaceutical companies to explore new areas of research, such as in metabolic disease.
Top ten biopharma deals of 2024 - Nature
WEBMay 31, 2024 · Eight of the top ten ranked by deal value involved technology platforms for developing a broad range of therapeutics, and three included Novartis as it expands its RNA and gene-based programs.
News | Timely industry updates for pharma and biotech leaders
WEBpharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Fresh from the biotech pipeline: record-breaking FDA approvals
WEBFeb 26, 2024 · Amgen’s tarlatamab could become the first delta-like ligand 3 (DLL3)-targeting bispecific T cell engager for small-cell lung cancer while Jazz Pharmaceuticals’ dual HER2 blocker zanidatamab ...